Please login to the form below
genomes
This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.
Covidian selection
Sometimes selection pressures work slowly, sometimes they work quickly. Daniel Lieberman’s excellent book, ‘The Story of the Human Body’ gives, for example, a fascinating description of how the human genome
Latest news
-
Merck gets first approval for MET inhibitor tepotinib in Japan
The approval comes on the back of a phase 2 study – called VISION – which enrolled patients with METex14-positive NSCLC based on a just-approved companion diagnostic developed by genome analysis
-
AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance
cases. It is also designed to protect against future variations of the virus, by targeting conserved epitopes from the whole virus genome. ... A vaccine to defend against current and future outbreaks of coronavirus and other respiratory viral pathogens
-
Allergan and Editas claim a CRISPR first in inherited blindness study
The historical CRISPR moment occurred in the phase 1/2 BRILLIANCE study, after the first LCA10 patient was dosed with the CRISPR genome editing medicine inside the body – or in vivo
-
Digital divergence
However, it’s the routineome, not the genome, we need to work on.
-
CRISPR gene-editing in cancer patients is safe, according to new study
The trial, which is the first sanctioned study to evaluate the clinical application of multiple CRISPR edits to the human genome, was undertaken by investigators at the Abramson Cancer Center of
More from news
Approximately 9 fully matching, plus 162 partially matching documents found.
Latest Intelligence
-
AI: the smart money is on the smart thinking
In the recent past, Qiagen also collaborated with Intel to find a solution that analyses human genomes for as little as $22, and the company has lately made headlines for being
-
A snapshot of Congenica
Our genome interpretation alone represents a c.95% reduction in staff time and cost. ... Scalability is another key factor. A single human genome consists of over 100GB of data. The Congenica platform processes, analyses and interprets thousands of
-
A snapshot of Microbiotica
create a database of reference genomes. ... In two-and-a-half years we have built an organisation of over 35 people with all the key disciplines and have outgrown our space at the Wellcome Genome Campus.
-
25 Women Leaders in UK Healthcare
She is also senior responsible officer (SRO) for the NHS Genomics Programme and has played a crucial role in enabling the groundbreaking 100, 000 Genomes Project by ensuring these healthcare scientists ... centre run by Illumina, and an automated
-
25 Women Leaders in UK Healthcare (part 2)
23. DR LARISSA KERECUK. Rare disease leader. England’s groundbreaking 100, 000 Genomes Project hasn’t been a scientific endeavour achieved exclusively through lab technology – it has required thousands of rare ... Dr Kerecuk is the lead for the
More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.
Latest appointments
-
Editas Medicine names James Mullen as chairman
He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
-
Editas Medicine adds to its board of directors
Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
-
Former GSK CEO joins Synthego’s advisory board
I look forward to contributing to the company’s success as the business extends further into the genome engineering market.”. ... Andrew’s appointment strengthens the company’s position as a leader in genome engineering solutions.”.
-
Paul Stockdale joins Oxford BioDynamics as CFO
A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
The UK has become the first country to take Whole Genome Sequencing, a cutting-edge biotechnology, into mainstream healthcare. ... Rather than looking at the genetic makeup of just the 20, 000 genes known to cause disorders, the whole genome is analysed.
-
Understanding COVID-19 and varying responses across the globe
COVID-19, was first sequenced in Wuhan, China in January 2020. This helped us to identify novel regions of the genome allowing for the development of diagnostic assays to detect the ... As more testing occurs and more data is collected, understanding of
-
If our patients are diverse, why are clinical trials so white?
In 2009, almost all participants (96%) involved in genome-wide association studies (GWAS) were of European descent.
-
What is changing in cardiovascular disease care?
Another area of focus in identifying people at risk is genome mapping, particularly around rarer conditions.
-
A uniquely English genomic medicine service
This process can take years, but Genomics England believes whole genome sequencing could provide much faster results. ... Helping these patients will mean carrying out whole genome sequencing upfront, before other genetic tests are conducted.
More from PMHub
Approximately 3 fully matching, plus 17 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Roche’s Ocrevus boasts positive long-term data in MS
- Leadership change within Bedrock Group
- Trials resume for AZ/Oxford University COVID-19 vaccine
- AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
